• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[糖尿病并发症及肝损伤患者血清中糖蛋白特定末端糖基残基水平的变化]

[Change in levels of specific terminal sugar residues of glycoproteins in sera of patients with complication of diabetes and liver injury].

作者信息

Nishida K, Nagamura Y, Ogitsu N, Ishiguro I, Ito M

机构信息

Department of Biochemistry, School of Hygiene, Fujita Health University, Toyoake.

出版信息

Rinsho Byori. 1990 Jul;38(7):835-7.

PMID:2402084
Abstract

The concentrations of specific terminal sugar residues of glycoproteins were determined in sera of patients with diabetes, liver injury or complication of both diseases. A significant increase in serum galactose (Gal) concentration was found in all patients. Serum N-acetylneuraminic acid-galactose (NANA-Gal) concentration was significantly decreased in patients with complication of diabetes and liver injury, whereas a high concentration of serum N-acetylneuraminic acid (NANA) was observed only in diabetic patients. Thus the determination of serum Gal and NANA-Gal should be added to one of clinical tests to provide new information on the pathological conditions of diabetes and liver injury.

摘要

测定了糖尿病患者、肝损伤患者或患有这两种疾病并发症患者血清中糖蛋白特定末端糖残基的浓度。所有患者的血清半乳糖(Gal)浓度均显著升高。糖尿病和肝损伤并发症患者的血清N-乙酰神经氨酸-半乳糖(NANA-Gal)浓度显著降低,而仅在糖尿病患者中观察到高浓度的血清N-乙酰神经氨酸(NANA)。因此,血清Gal和NANA-Gal的测定应添加到临床检测项目中,以提供有关糖尿病和肝损伤病理状况的新信息。

相似文献

1
[Change in levels of specific terminal sugar residues of glycoproteins in sera of patients with complication of diabetes and liver injury].[糖尿病并发症及肝损伤患者血清中糖蛋白特定末端糖基残基水平的变化]
Rinsho Byori. 1990 Jul;38(7):835-7.
2
[Change in levels of specific terminal sugar residues of glycoproteins in sera of patients with malignant tumor].[恶性肿瘤患者血清中糖蛋白特定末端糖残基水平的变化]
Rinsho Byori. 1993 Aug;41(8):937-9.
3
[Value of N-acetylneuraminic acid (NANA) in the serum of patients with gynecologic cancers].[N-乙酰神经氨酸(NANA)在妇科癌症患者血清中的价值]
Zentralbl Gynakol. 1985;107(3):175-8.
4
[Significance of N-acetyl neuraminic acid analysis in clinical tests].
Nihon Rinsho. 1989 Dec;48 Suppl:462-4.
5
[Differential quantitative changes of N-acetylneuraminic acid and L-fucose in the blood of patients with diabetes mellitus and other intercurrent diseases].[糖尿病及其他并发疾病患者血液中N-乙酰神经氨酸和L-岩藻糖的差异定量变化]
Prensa Med Mex. 1977 Mar-Apr;42(3-4):120-6.
6
[Clinical significance of serum sialic acid in the diagnosis of diabetic diseases].
Nihon Rinsho. 1990 Dec;48 Suppl:349-52.
7
[Significance of serum sialic acid analysis. (2). Glycoproteins containing sialic acids].[血清唾液酸分析的意义。(2). 含唾液酸的糖蛋白]
Rinsho Byori. 1974 Oct;22(10 Suppl):159.
8
Serum sialic acid enzymatic assay based on microtitre plates: application for measuring capillary serum sialic acid concentrations.基于微量滴定板的血清唾液酸酶法测定:用于测量毛细血管血清唾液酸浓度的应用
Br J Biomed Sci. 1993 Jun;50(2):164-7.
9
[Serum levels of sialic acid in patients with type 1 diabetes mellitus in relation to the incidence of late complications].1型糖尿病患者血清唾液酸水平与晚期并发症发生率的关系
Cas Lek Cesk. 1996 Nov 20;135(22):723-5.
10
[Significance of certain neoplastic markers in a series of patients with lung cancer].[一系列肺癌患者中某些肿瘤标志物的意义]
Minerva Med. 1984 Apr 28;75(18):1041-6.